Susceptibility (MODS) culture or the Xpert MTB/RIF assay might be used to expand bacteriological diagnosis. However data from children are more limited. We prospectively compared MODS and Xpert MTB/RIF with standard microscopy and culture using the BD MGIT 960 system among 1442 Kenyan children with suspected TB. 97 specimens from 54 children were TB culture-positive: 91 (94%) by MGIT and 74 (76%) by MODS (p = 0.002). 72 (74%) culture-positive and 7 culture-negative specimens were Xpert MTB/RIF positive. Xpert MTB/RIF specificity was 100% (99.7-100%) among 1164 specimens from 892 children in whom TB was excluded, strongly suggesting all Xpert MTB/RIF positives are true positives. The sensitivity of MGIT, MODS and Xpert MTB/RIF was 88%, 71% and 76%, respectively, among all 104 true positive (culture and/or Xpert MTB/RIF positive) specimens. MGIT, MODS and Xpert MTB/RIF on the initial specimen identified 40/51 (78%), 33/51 (65%) and 33/51 (65%) culture-confirmed pulmonary TB cases, respectively; Xpert MTB/RIF detected 5 additional culture-negative cases. The high sensitivity and very high specificity of the Xpert MTB/RIF assay supports its inclusion in the reference standard for bacteriological diagnosis of childhood TB in research and clinical practice.
Definitive diagnosis of tuberculosis (TB) rests on detection of M. tuberculosis from clinical specimens, but is difficult in children. While sputum smear microscopy underpins the WHO DOTS and Stop TB strategies for TB diagnosis in adults 1 , obtaining sputum is more difficult in children, and the yield of microscopy alone is very poor due to small numbers of bacilli in clinical specimens. Bacteriological diagnosis therefore depends on mycobacterial culture 2 .
Strengthening laboratory capacity is a key component of the Stop TB Strategy and Global Plan to Stop TB 1, 3 . Commercial liquid culture methods like the BACTEC Mycobacteria Growth Indicator Tube (MGIT) system (BD Diagnostics, Sparks, MD, USA) offer higher sensitivity and more rapid results than traditional solid media. However, barriers to their uptake include cost, a lack of technically trained personnel, and the need for biosafety level 3 facilities 3 .
Microcolony culture techniques such as the Microscopic Observation Drug Susceptibility (MODS) assay have several potential advantages over conventional culture methods in low resource settings, including high sensitivity; more rapid results that include drug susceptibility testing (DST); lower cost; and less stringent biosafety requirements making it applicable in biosafety level 2 facilities 4 . However only limited data exist on their use in children [5] [6] [7] , and no studies have compared MODS with MGIT for diagnosis of TB in young children; nor evaluated MODS yield from induced sputum samples, despite good evidence and international recommendations supporting sputum induction for childhood TB diagnosis 2, 8 .
The Xpert MTB/RIF real-time PCR assay (Cepheid, Sunnyvale, CA, USA) offers a rapid and operationally simpler alternative to culture for detection of M. tuberculosis and rifampicin resistance 9, 10 . A recent meta-analysis suggests modest sensitivity and high specificity for paediatric TB diagnosis 11 , and the latest WHO childhood TB guidelines (2014) recommend Xpert MTB/RIF as an alternative to conventional microscopy and culture -but acknowledge the "very low quality of evidence" 2 . platform (Hain Lifescience GmbH, Nehren, Germany). The Xpert MTB/RIF assay (version G4) was performed at the end of the study on specimens from all children treated for confirmed, highly probable or possible TB, and from children in whom TB had been excluded. Laboratory procedures were externally monitored through the UK NEQAS quality assurance scheme and annual Good Clinical Laboratory Practice audits (Qualogy, UK).
In order to compare the performance of MGIT and MODS, and to prevent observer bias in the interpretation of either result, laboratory technologists were blinded to the identity of the MODS portion of each specimen. Specimens were instead identified by an electronically generated random numeric code, the key to which was held by the Principal Investigator.
Statistical analysis.
Data were analyzed at both the patient and the specimen level. We first performed a per patient analysis to compare the sensitivity of smear microscopy, MGIT, MODS and Xpert MTB/RIF for identification of culture confirmed pulmonary TB cases. We then included all specimens (pulmonary and extra-pulmonary) in a per specimen analysis to calculate the sensitivity of each method against the existing reference standard of a positive M. tuberculosis culture (by MGIT and/or MODS).
To explore the specificity of Xpert MTB/RIF we calculated the proportion of specimens from Not TB cases that were Xpert MTB/RIF positive. Having established the very high specificity of the Xpert MTB/RIF assay, we then repeated the per specimen analysis using a composite reference standard incorporating Xpert MTB/RIF, such that a specimen was considered positive if either culture or Xpert MTB/RIF identified M. tuberculosis.
We used McNemar's χ 2 test to compare proportions between tests on paired aliquots of the same sample. To investigate any learning effect as laboratory staff became more experienced with MODS we performed the χ 2 test for trend in the proportion of M. tuberculosis culture positive specimens identified by MODS in each quarter, and the Wilcoxon rank sum test to compare MODS time to detection (TTD) in the first and second years of the study. We used the Wilcoxon signed rank test to compare TTD of MTBC by MODS and MGIT. Associations with a positive Xpert MTB/RIF assay were explored using univariable and multivariable logistic regression models adjusted for clustering at the patient level.
Ethical approval and informed consent. The study was approved by the Kenya National Ethics
Committee. All study procedures were performed in accordance with relevant guidelines and regulations. A parent or guardian provided written informed consent.
Data availability. The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request. 
Results
We identified 1500 children with features of suspected TB, 1442 of whom were investigated for TB ( Fig. 2 ). Active TB was diagnosed in 212 (14.7%) children, including 54 (25.5%) with Culture-confirmed TB, 63 (29.7%) with Highly Probable TB, and 95 (44.8%) with Possible TB. Most cases (185, 87%) had pulmonary TB (PTB). Baseline demographic and clinical characteristics are summarized in Table 1 . In keeping with previous studies, the proportion of cases that were bacteriologically confirmed was higher among older children.
Per patient analysis of pulmonary TB cases. There were 51 cases of Culture-confirmed pulmonary TB.
Smear microscopy, MGIT and MODS on the initial sputum specimen identified M. tuberculosis in 13 (25%), 40 (78%) and 33 (65%) cases, respectively ( Table 2) . Sensitivity was highest for each method among smear positive samples; Xpert MTB/RIF identified 100% of smear-positive cases and 53% of smear-negative cases on the first sputum specimen ( Table 2) .
Second and third sputum specimens were obtained from 237 (16%) and 102 (7%) children, respectively. Eight (16%) culture confirmed PTB cases were culture negative from the initial sample but grew M. tuberculosis from a 
Patient demographics
Age Table 1 . Baseline characteristics of children with and without TB. 1 IQR, interquartile range. 2 FTT, failure to thrive. 3 Six patients with pulmonary TB also had extrapulmonary TB (4 with culture confirmed TB, 2 that were treated for possible TB). subsequent sputum sample. MGIT, MODS and Xpert MTB/RIF each demonstrated a modest incremental yield from additional specimens ( Table 3 ). None of the 8 initial culture-negative specimens from confirmed PTB cases were Xpert MTB/RIF positive. However Xpert MTB/RIF did detect M. tuberculosis in sputum from 5 additional children with culture negative pulmonary TB (3 with clinically Highly Probable TB and 2 who were treated for Possible TB).
Per specimen analysis of pulmonary and extra-pulmonary specimens combined.
A total of 2085 specimens were obtained for mycobacterial culture. We were unable to do MODS on 182 samples due to holiday staffing shortages (169) or insufficient sample (13) . A total of 1903 specimens were therefore included in the analysis, of which 1802 (95%) were sputum specimens, 33 (2%) were smear positive, and 97 (5%) were M. tuberculosis culture positive (Supplementary Appendix, Table S1 ). MGIT was more sensitive than MODS overall (93.8% vs 76.3%, p = 0.002), among all sputum specimens, among induced sputum specimens, and among specimens from both younger and older children (Table 4 ). There was weak evidence of an increase in MODS sensitivity (χ 2 test for trend p = 0.038) and a decrease in TTD over time, with a median TTD of 16 (IQR 7 to 21) days in 2010 compared with 10 (7 to 14) days in 2011 (p = 0.052; Supplementary Appendix, Fig. S1 ). Overall, TTD was slightly shorter for MODS than MGIT (11 [IQR 6 to 15] days versus 12 [7 to 17] days, p = 0.001).
Discordant culture results were obtained for 29 specimens. Independent bacteriological confirmation of M. tuberculosis was available for 21/29 of these specimens, either by the Xpert MTB/RIF assay on the original specimen (15/29) and/or by isolation of M. tuberculosis from an independent specimen from the same patient (Supplementary Appendix, Table S2 ). The clinical picture strongly supported the presence of M. tuberculosis complex in the remaining 8 culture-discordant samples: 5 MGIT+/MODS− specimens came from children with clinically Highly Probable TB prior to culture results; 2 MGIT−/MODS+ specimens came from children treated empirically for TB prior to the culture result although they did not meet the stringent definition Table 3 . Cumulative sensitivity (incremental yield) of serial sputum specimens from patients with culture confirmed pulmonary TB. *Cum. yield = cumulative sensitivity of serial sputum specimens. In 4 (8%) cases of culture-confirmed pulmonary TB, culture confirmation was obtained from a subsequent specimen (n = 1) or from a specimen excluded from the analysis because MODS culture was not performed (n = 3). Table S2 ). All were the only positive cultures in their batch, arguing against cross-contamination causing the discordance. Even if cross-contamination were the cause and these specimens considered culture negative, MGIT would remain more sensitive than MODS (95.5% vs 80.9%, p = 0.005). Xpert MTB/RIF identified 72/97M. tuberculosis culture positive specimens, giving a sensitivity compared to culture of 74.2% (95% CI 64.3 to 82.6). Xpert MTB/RIF was also positive on 5/86 (6%) specimens from patients with culture-negative but clinically highly probable TB, and 2/179 (1%) specimens from children treated for possible TB. No other specimens were Xpert MTB/RIF positive, including none of 1164 specimens obtained from children in whom TB was subsequently excluded -giving a specificity of 100% (1 sided 97.5% CI 99.7 to 100%) and strongly suggesting positive Xpert MTB/RIF results should be interpreted as true positives.
MGIT positive
Against the composite reference standard of a positive TB culture and/or Xpert MTB/RIF result, the sensitivity of TB culture was 93.3% (86.6 to 97.3), compared with 76.0% (66.6 to 83.8) for Xpert MTB/RIF (p = 0.002; Table 5 ). The sensitivity of MGIT and MODS culture alone were 87.5% (79.6 to 93.2) and 71.2% (61.4 to 79.6), respectively. Table 6 shows Xpert MTB/RIF sensitivity against the composite reference standard, broken down by smear status, specimen type, age and HIV status. Sensitivity was higher for smear positive specimens (100% compared with 65% for smear negative specimens, p < 0.001), with a trend towards higher sensitivity among sputum samples. Neither age nor HIV status were associated with Xpert MTB/RIF yield in univariable or multivariable analyses.
Xpert MTB/RIF identified rifampicin resistance in 4 specimens from the same child, all of which were confirmed resistant to rifampicin by MODS and the GenoType MTBDRplus assay. MODS did not identify any other rifampicin resistant isolates.
Discussion
The lack of reliable diagnostic tools is the single greatest obstacle to improved childhood TB case management, particularly in low resource settings where the disease burden is greatest. Expansion of TB laboratory diagnostic capacity provides an opportunity to improve both diagnosis and surveillance in many settings 3 . However good quality data on the performance of each method are required to optimize their use and interpretation.
Few studies have compared laboratory methods for childhood TB diagnosis. Limitations of existing studies include small numbers of confirmed TB cases [5] [6] [7] 14, [17] [18] [19] [20] [21] [22] , particularly among young children in whom diagnosis is most challenging [5] [6] [7] 14, 19, 22 , and exclusion of 'gold standard' methods for specimen collection and/or mycobacterial culture [5] [6] [7] 17, 20, [23] [24] [25] [26] . Strengths of this study include the use of both sputum induction and liquid mycobacterial culture in keeping with current international recommendations 2 , and rigorous diagnostic assignments based on detailed clinical assessment and follow up. Prospective recruitment of all children who met broad, pre-defined inclusion criteria also ensures generalizability to a wide range of settings and clinical syndromes, including among children under 5 years who accounted for 81% of those investigated and half of all confirmed cases.
While comparison of culture yield between studies is hampered by widely varying clinical definitions, specimen types and culture methods, the proportion of culture-confirmed cases in our study is consistent with other studies using liquid mycobacterial culture for paediatric diagnosis 5, 8, 14, 18, 20, [26] [27] [28] [29] [30] .
In our study MGIT was more sensitive than MODS culture. This is in keeping with the only other published study comparing MGIT with MODS for paediatric TB diagnosis 5 . Importantly we were also able to demonstrate the higher yield of MGIT for culture of paediatric induced sputum samples. These results contrast with other studies in adults in which MODS compared more favourably with MGIT 4 . The paucibacillary nature of childhood TB may have a role, and variation between centres also suggests MODS performance is operator dependent 4 . In support of this, even after one month residential training with an experienced team, we were able to demonstrate a learning effect with increasing MODS yield and reducing time to detection during the two years of the study. We did not compare MODS with culture on solid media, however other studies have shown MODS to be superior to Lowenstein Jensen media for diagnosis of childhood TB 6, 7, 26 .
Against a reference standard of mycobacterial culture, Xpert MTB/RIF sensitivity was similar to other paediatric studies 11 , and comparable to MODS -in keeping with the only other study to compare the two methods 29 . Significantly, a combination of culture and Xpert MTB/RIF increased bacteriological yield without compromising specificity. Importantly, we were able to confirm the very high specificity of Xpert MTB/RIF in a large sample of specimens from children in whom TB had been excluded by careful clinical, radiological and laboratory assessment and follow up. Positive Xpert MTB/RIF results have been reported in a small number of child TB suspects who did well at follow up without TB treatment 11, 24 . However the very high precision with which we were able to demonstrate 100% specificity of Xpert MTB/RIF in a carefully characterized group of children without TB suggests that these apparent false positive results from TB suspects in very high burden settings may have represented self-limiting pulmonary tuberculosis. This is well recognized in the pre-chemotherapy literature 31 .
Our primary analysis compared Xpert MTB/RIF sensitivity with the current culture reference standard. Having demonstrated the very high specificity of Xpert MTB/RIF we then repeated the analysis using a composite reference standard of positive culture or Xpert MTB/RIF. Composite reference standards should be used with care 32 . However, given the equivalent high specificities of Xpert MTB/RIF and mycobacterial culture, incorporation bias in favour of Xpert MTB/RIF is unlikely. Furthermore, misclassification bias arising from the imperfect sensitivity of culture may bias estimates of the accuracy of Xpert MTB/RIF culture alone is used as the reference 33, 34 . We believe the composite reference standard therefore provides a fairer comparison of the two methods, and a better estimate of the true sensitivity of the Xpert MTB/RIF assay.
One potential limitation of our study is that molecular typing was not performed on MGIT-MODS discordant culture isolates to exclude cross-contamination. Nevertheless there was strong microbiological and/or clinical evidence to corroborate the positive culture in every case. In addition, negative controls in every MGIT batch and MODS plate provided no evidence of cross-contamination throughout the study, consistent with the very low prevalence and concentrations of M. tuberculosis in these paediatric specimens.
Due to finite resources, most children only had a single sputum sample obtained. Although this and other studies show the incremental yield of additional specimens where obtained, analysis of a single specimen is likely to reflect practice in most low resource settings due to the incremental cost of processing additional specimens.
In conclusion, our results underline the imperfect sensitivity of all currently available methods for bacteriological diagnosis of childhood TB. The choice of method in any particular setting depends on several factors including prevalence of TB and drug resistance; resources available to risk stratify patients for testing; test sensitivity, cost 35 , time to detection; and the availability of trained staff and laboratory biosafety facilities. Our data confirm the superior sensitivity of MGIT compared with MODS and Xpert MTB/RIF. Although MODS may have a role in some settings, the operationally simpler Xpert MTB/RIF assay was as sensitive as MODS, demonstrated equivalent specificity to MGIT, and combined with MGIT it optimized bacteriological yield. Together these results strengthen the evidence base for inclusion of Xpert MTB/RIF in the reference standard for bacteriologically confirmed childhood TB in both WHO clinical guidelines 35 Table 6 . Sensitivity of the Xpert MTB/RIF assay against the composite reference standard.
